Metraipolis › archive › dc_7de07984ba8d

Survival Outcomes of Adjuvant Nivolumab after Neoadjuvant Chemotherapy in Esophageal Squamous Cell Carcinoma — Europe PMC PMID:42528212

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42528212
DOI
10.5761/atcs.oa.26-00107
License (as archived)
solo-consultazione
Archived
2026-11-07T06:40:34.944Z
SHA-256 of the archived text
4b085e2f12fbf00bb25f6de2a295284ec5fb3dda17ba8d062352584a68f813a2
Stable URL of this page
https://metraipolis.com/documento/dc_7de07984ba8d

How to cite

Survival Outcomes of Adjuvant Nivolumab after Neoadjuvant Chemotherapy in Esophageal Squamous Cell Carcinoma — Europe PMC PMID:42528212 — Europe PMC (en), https://europepmc.org/article/MED/42528212 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_7de07984ba8d (Metraipolis archive dc_7de07984ba8d, sha256 4b085e2f12fbf00bb25f6de2a295284ec5fb3dda17ba8d062352584a68f813a2)
BibTeX
@misc{dc7de07984ba8d,
  title = {Survival Outcomes of Adjuvant Nivolumab after Neoadjuvant Chemotherapy in Esophageal Squamous Cell Carcinoma — Europe PMC PMID:42528212},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42528212},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_7de07984ba8d; sha256 4b085e2f12fbf00bb25f6de2a295284ec5fb3dda17ba8d062352584a68f813a2},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42528212. Agents can read the archived copy with the MCP tool read_document.